CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Have you ever looked into the face of evil? Today, we’re taking a horrifying journey into the depths of the worst of humanity ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...

Scientists have discovered a way to make gene editing safer and more precise — and it's an advance that could help bolster ...

CRISPR therapies offer precise gene-editing solutions for treating genetic disorders and other complex diseases. Rising prevalence of genetic conditions drives adoption, and emerging CRISPR-based ...

REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

MB-111 is a potential first-in-class, single-dose in vivo CRISPR gene editing therapy for persistent chylomicronemiaOral presentation highlights safe, robust, and durable reduction of apoC-III and ...

Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.